Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDB vs MRNA✓SelectedUSD · MRNAMDB vs MRNA performance historyLatest closeAs of-1.64%11/13
Stock and ETF performance explorer

MDB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+296.2%
MRNA return
+915.3%
Excess return
-619.1%
Maximum drawdown
-76.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.6%-3.4%+1.8%-1.3%
7D+6.8%-12.1%+19.0%+8.3%
30D-6.2%-1.3%-4.9%-6.2%
3M-29.2%+250.9%-280.2%-44.6%
6M+10.3%+343.0%-332.7%-18.1%
YTD-20.4%+657.4%-677.8%-47.6%
1Y-4.8%+794.9%-799.7%-39.6%
3Y-11.6%+218.1%-229.7%-35.9%
5Y-41.0%-3.4%-37.7%-49.3%
All+296.2%+915.3%-619.1%+175.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling